The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
VSee Health divested its subsidiary VSee Lab to former co-CEO Milton Chen in exchange for shares, significantly narrowing projected net losses and leaving Dr. Imoigele Aisiku as the sole CEO. Concurrently, VisionWave Holdings agreed to acquire a 52% stake in Foresight Autonomous Holdings with a two-year value protection mechanism for the shares involved. Additionally, Visionary Holdings received a Nasdaq delisting notice and plans to appeal the decision before a formal hearings panel.